Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Stock Price

OBIOStock

$5.45+48.10%52W

Market Cap$327.57M

P/E—

PEG Ratio—

Div yield—

Beta0.56

OBIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)10.94%

Price vs S&P 500 (4W)-11.47%

VGM Score51.74

Book Value / Share (Quarterly)$0.49

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)111.68%

Cash Flow / Share (Quarterly)$-0.98

Price vs S&P 500 (YTD)19.40%

Gross Margin (TTM)99.51%

Net Profit Margin (TTM)-184.39%

EPS (TTM)$-1.00

10-Day Avg Trading Volume0.26M

EPS Excl Extra (TTM)$-1.00

Revenue Growth (5Y)42.49%

EPS (Annual)$-1.10

ROI (Annual)-67.87%

Gross Margin (Annual)99.43%

Net Profit Margin (5Y Avg)-1115.45%

Cash / Share (Quarterly)$1.83

Revenue Growth QoQ (YoY)-89.47%

ROA (Last FY)-45.88%

Revenue Growth TTM (YoY)986.14%

EBITD / Share (TTM)$-0.96

ROE (5Y Avg)-227.70%

Operating Margin (TTM)-181.36%

Cash Flow / Share (Annual)$-0.87

P/B Ratio11.13x

P/B Ratio (Quarterly)8.78x

Net Income / Employee (Annual)$-612,800

EV / Revenue (TTM)10.69x

Net Interest Coverage (TTM)-57.95x

ROA (TTM)-54.09%

EPS Incl Extra (Annual)$-1.10

Current Ratio (Annual)6.45x

Quick Ratio (Quarterly)8.17x

3-Month Avg Trading Volume0.35M

52-Week Price Return48.10%

Revenue / Employee (TTM)$371,800

P/S Ratio (Annual)9.78x

Asset Turnover (Annual)0.29x

52-Week High$6.50

Operating Margin (5Y Avg)-1154.70%

EPS Excl Extra (Annual)$-1.10

CapEx CAGR (5Y)-1.96%

26-Week Price Return20.84%

Quick Ratio (Annual)6.37x

13-Week Price Return48.10%

Total Debt / Equity (Annual)0.23x

Current Ratio (Quarterly)8.26x

Enterprise Value$341.94M

Revenue / Share Growth (5Y)31.23%

Asset Turnover (TTM)0.29x

Revenue / Employee (Annual)$389,300

Inventory Turnover (Annual)0.79x

Pretax Margin (Annual)-157.40%

Cash / Share (Annual)$1.87

3-Month Return Std Dev62.49%

Gross Margin (5Y Avg)95.31%

Net Income / Employee (TTM)$-685,600

ROE (Last FY)-83.15%

Net Interest Coverage (Annual)-14.82x

EPS Basic Excl Extra (Annual)$-1.10

Receivables Turnover (TTM)477.25x

Total Debt / Equity (Quarterly)1.18x

EPS Incl Extra (TTM)$-1.00

Receivables Turnover (Annual)358.10x

ROI (TTM)-88.95%

P/S Ratio (TTM)10.24x

Pretax Margin (5Y Avg)-1115.45%

Revenue / Share (Annual)$0.70

Price vs S&P 500 (52W)32.57%

Year-to-Date Return31.33%

5-Day Price Return-7.78%

EPS Normalized (Annual)$-1.10

ROA (5Y Avg)-76.56%

Net Profit Margin (Annual)-157.40%

Month-to-Date Return-12.38%

EBITD / Share (Annual)$-1.08

Operating Margin (Annual)-154.73%

LT Debt / Equity (Annual)0.23x

ROI (5Y Avg)-99.22%

LT Debt / Equity (Quarterly)1.18x

EPS Basic Excl Extra (TTM)$-1.00

P/B Ratio (Annual)3.70x

Inventory Turnover (TTM)0.72x

Pretax Margin (TTM)-184.39%

Book Value / Share (Annual)$1.11

Price vs S&P 500 (13W)45.41%

Beta0.56x

Revenue / Share (TTM)$0.50

ROE (TTM)-125.78%

52-Week Low$3.26

vGradeF

gGradeB

mGradeB

vgmGradeC

OBIO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	-$0.37	-$0.37	+0.11%(+$0.00)
Q4 2025	Mar 12, 2026	-$0.38	$0.26	+168.70%(+$0.64)
Q3 2025	Nov 10, 2025	-$0.43	-$0.40	+6.72%(+$0.03)
Q2 2025	Aug 12, 2025	-$0.51	-$0.50	+1.41%(+$0.01)

OBIO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares	F	B	B	10.2x	42.5%	99.5%	-181.4%	$5.45
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Orchestra BioMed Holdings, Inc. Ordinary Shares

Orchestra BioMed Holdings Inc is a biomedical company that develops innovative medical device technologies through strategic partnerships with established device manufacturers. The company's flagship products include BackBeat Cardiac Neuromodulation Therapy for treating hypertension and Virtue Sirolimus AngioInflusionBalloon for treating atherosclerotic artery disease. Its partnership-enabled model reduces development risk by sharing the burden with commercialization partners while accelerating time to market for its product candidates.

OBIO Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.40

Revenue estimate$103,500

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

OBIO Insider Transactions

BuySep 3, 2026
HOCHMAN DAVID P
Chief Executive Officer
Shares: 10,000Value: $47,900
SellSep 1, 2026
SHERMAN DARREN
President
Shares: 15,000Value: $74,100
BuyAug 26, 2026
SHERMAN DARREN
President
Shares: 2,000Value: $10,660
SellAug 3, 2026
SHERMAN DARREN
President
Shares: 15,000Value: $61,350

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment
SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses
NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$3.26

High$6.50